Julian KNOLL

This project aims to develop a novel therapies for ischemic stroke using new compounds to reduce brain damage and prevent disability in the late stage after reperfusion therapy. Specific aims include developing a drug delivery system to transport active pharmaceutical ingredients to the damaged tissue and assessing its efficacy in an animal model. If successful, this approach could offer new insights into stroke therapy, which will be used to improve the quality of life for stroke patients.